You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

APD334

Showing 1 - 22 of 22
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary Biliary Cholangitis Trial in Australia, New Zealand, United States (APD334)

Terminated
Has Results
  • Primary Biliary Cholangitis
  • APD334
  • Sacramento, California
  • +8 more
Feb 28, 2022

Atopic Dermatitis Trial in United States (Etrasimod, Etrasimod matching )

Completed
  • Atopic Dermatitis
  • Tucson, Arizona
  • +10 more
Nov 18, 2021

IBD, Skin Extra-intestinal Manifestations Trial in Leuven, Hamburg, Belgrade (APD334)

Terminated
Has Results
  • Inflammatory Bowel Diseases
  • Skin Extra-intestinal Manifestations
  • APD334
  • Leuven, Belgium
  • +2 more
Dec 5, 2020

Crohn's Disease Trial in Worldwide (Etrasimod, Placebo)

Not yet recruiting
  • Crohn Disease
  • (no location specified)
Aug 29, 2021

Ulcerative Colitis Trial in Knoxville (Etrasimod)

Recruiting
  • Ulcerative Colitis
  • San Francisco, California
  • +12 more
Jan 18, 2023

Alopecia Areata Trial in Canada, United States (Etrasimod, Placebo)

Active, not recruiting
  • Alopecia Areata
  • Scottsdale, Arizona
  • +41 more
Jan 4, 2023

Atopic Dermatitis, Atopic Dermatitis, Unspecified, Eczema Trial in United States (etrasimod, Placebo)

Recruiting
  • Atopic Dermatitis
  • +3 more
  • Fountain Valley, California
  • +21 more
Feb 22, 2023

Ulcerative Colitis Trial in Worldwide (Etrasimod, Placebo)

Completed
Has Results
  • Ulcerative Colitis
  • Birmingham, Alabama
  • +126 more
Nov 24, 2021

Ulcerative Colitis Trial in Japan (Etrasimod, Placebo)

Recruiting
  • Ulcerative Colitis
  • Toyohashi-shi, Aichi- KEN, Japan
  • +70 more
Jan 3, 2023

Ulcerative Colitis Trial in Japan (Etrasimod, Placebo)

Active, not recruiting
  • Ulcerative Colitis
  • Nagoya-shi, Aichi, Japan
  • +29 more
Dec 8, 2021

Ulcerative Colitis Trial in Worldwide (Etrasimod, Placebo)

Completed
Has Results
  • Ulcerative Colitis
  • Birmingham, Alabama
  • +133 more
Mar 10, 2021

Ulcerative Colitis Trial in Worldwide (Etrasimod)

Recruiting
  • Ulcerative Colitis
  • Dothan, Alabama
  • +600 more
Jan 11, 2023

Eosinophilic Esophagitis Trial in Worldwide (Etrasimod, Placebo)

Active, not recruiting
  • Eosinophilic Esophagitis
  • Birmingham, Alabama
  • +222 more
Dec 8, 2022

Crohn's Disease Trial in Worldwide (Etrasimod, Placebo)

Recruiting
  • Crohn's Disease
  • Dothan, Alabama
  • +265 more
Mar 17, 2022

Ulcerative Colitis Trial in Worldwide (Etrasimod, Placebo)

Recruiting
  • Ulcerative Colitis
  • Dothan, Alabama
  • +349 more
Jan 18, 2023

Ulcerative Colitis Trial in Worldwide (Etrasimod, Placebo)

Completed
  • Ulcerative Colitis
  • Dothan, Alabama
  • +406 more
Jan 11, 2022

Migraine Trial in United States (Rimegepant 75mg daily dosing, Rimegepant 75mg every other day dosing, Placebo comparator

Recruiting
  • Migraine
  • Rimegepant 75mg daily dosing
  • +2 more
  • Tempe, Arizona
  • +55 more
Jan 18, 2023

Ulcerative Colitis Trial in Worldwide (Etrasimod, Placebo)

Completed
Has Results
  • Ulcerative Colitis
  • Dothan, Alabama
  • +314 more
Nov 28, 2022

Moderately to Severely Active Ulcerative Colitis Trial in Xi'an (Etrasimod, Placebo)

Recruiting
  • Moderately to Severely Active Ulcerative Colitis
  • Xi'an, Shanxi, China
    The First Affiliated Hospital of Fourth Military Medical Univers
Nov 25, 2019

Compliance, Patient Trial (HomeChoice Claria APD machine with SHARESOURCE)

Unknown status
  • Compliance, Patient
  • HomeChoice Claria APD machine with SHARESOURCE
  • (no location specified)
Nov 16, 2019

COVID-19 Trial in Argentina, Puerto Rico, United States (Bamlanivimab, Etesevimab, Placebo)

Completed
Has Results
  • COVID-19
  • Birmingham, Alabama
  • +140 more
Jun 7, 2022

Bone Metastases, Breast Cancer, Lung Cancer Trial (zoledronic acid)

Completed
  • Bone Metastases
  • +3 more
  • zoledronic acid
  • (no location specified)
Dec 20, 2010